Tony De Sousa

Innovation and the Future of Pharmacovigilance

Today's conversation comes alive with Tony De Sousa, the Global Head of Countries and Regions at Novartis, leading the discourse on a fascinating journey through the world of pharmacovigilance. Tony's intriguing journey from nursing to becoming a significant player in one of the world's largest pharmaceutical companies is sure to captivate you. We delve deep into the evolution of PV, contemplating the influence of European regulations and the complexities of leading a global team.
But that's not all. We also engage in a spirited discourse him being a global leader from the pharmaceutical industry. It provides an enlightening perspective on how personal experiences with cultural shocks have continuously shaped his leadership approach. We journey through the impacts of COVID-19 on work and life, leading to a shift in priorities. He also shares some invaluable insights into the increasingly complex regulatory environment in various regions, and how his company has succeeded in preparing for PV inspections.
Rounding off our conversation, we begin to examine the future of PV and the exciting role that artificial intelligence (AI) may play in this domain. The conversation highlights the current challenges and limitations of AI in PV while emphasizing the importance of risk management in patient safety. Finally, Tony offers his insights on the future of PV, the marriage of PV with data mining and the need for regulatory support for AI advancements. Don't miss out on this riveting conversation that provides a sneak peek into the future of PV.